Aurobindo Pharma has received tentative approval from US Food and Drug Administration to manufacture and market Efavirenz+Lamivudine+Tenofovir Disoproxil Fumarate tablets in 600mg/300mg/300mg strengths. The drug can be used alone or in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and adolescents. equity tips
Please remember...your comment should not contain nudity or vulger language in addition to advertisement of your blog/site or any product ...and should not hurt the readers emotions...if that will be case it will be removed on first review of admin staff... Regards
Aurobindo Pharma has received tentative approval from US Food and Drug Administration to manufacture and market Efavirenz+Lamivudine+Tenofovir Disoproxil Fumarate tablets in 600mg/300mg/300mg strengths. The drug can be used alone or in combination with other antiretrovirals for the treatment of HIV-1 infection in adults and adolescents.
ReplyDeleteequity tips